ArticleBMC microbiology2026
A longitudinal evaluation of localised chronic Pseudomonas aeruginosa infection in cystic fibrosis rat models.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recurrent bacterial infections with Pseudomonas aeruginosa result in chronic airway inflammation, lung damage and eventual respiratory failure, and are the major cause of morbidity and mortality in people with cystic fibrosis (CF). Animal models are essential for understanding disease progression and assessing potential treatments in the presence of infection. Previously reported P. aeruginosa lung infection rodent models for CF research have weaknesses that include being acute rather than chronic infections, high levels of associated mortality, use laboratory strains of P. aeruginosa, or do not utilise CF rodents. The aim of this study was to create a localised single-lung P. aeruginosa infection in wildtype and two CF rat models, by using a miniature bronchoscope to deliver bacteria embedded in agar beads generated from a clinical CF bacterial isolate. Cohorts of animals were assessed at days 7, 14, 21 and 63. The number of colony forming units were measured, along with bronchoalveolar lavage, flexiVent mechanics, X-ray Velocimetry (XV) ventilation analysis, and histopathology. The resulting infection was well tolerated by all animals of all genotypes with no mortality associated with the procedure or infection. The right-lung exhibited localised acute bronchopneumonia and lymphocytic vasculitis early, progressing to chronic interstitial pneumonia with fibrosis and emphysema. Bacteria persisted for 9 weeks (63 days) in all genotypes, with lung mechanics changes observed by day 63 of the infection. The precise delivery of bacterial laden beads using a miniature bronchoscope generated a controlled and reproducible infection that persisted for up to nine weeks, with minimal impact on animal health.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.